Core Scientific Executive Todd Duchene Sells 10,000 Shares
Key Points
The transaction involved 10,000 shares executed at a weighted average price of $16.234 per share, resulting in a total value of ~$162,300 on August 31, 2026.
The executive traded shares equal to 0.52% of the stake held before the filing.
The sale consisted entirely of directly held shares, leaving the executive with ~1.9 million shares in a direct capacity.
The transaction was conducted under a Rule 10b5-1 trading plan, representing a pre-scheduled liquidity event.
Todd M. Duchene, Chief Legal and Administrative Officer at Core Scientific, Inc. (NASDAQ:CORZ), sold 10,000 shares of common stock on Aug. 31, 2026, according to a recent SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Transaction value | $162,300 |
| Shares sold | 10,000 |
| Post-transaction shares (directly held) | 1,927,896 |
| Post-transaction value | $31.4 million |
Transaction value based on SEC Form 4 weighted average sale price ($16.23); post-transaction value based on Aug. 31, 2026 market close ($16.30).
Key questions
- What is the significance of this transaction relative to the executive's total equity position?
The 10,000 shares sold represent 0.52% of the executive's prior holdings, which indicates a limited adjustment to the overall position. Following this transaction, the executive continues to hold 1,927,896 shares directly, a position valued at ~$31.4 million as of the Aug. 31, 2026, market close. - How does the timing of this sale relate to the executive's trading plan?
This sale was non-discretionary and was executed pursuant to a Rule 10b5-1 trading plan adopted on Dec. 5, 2025. These plans allow corporate insiders to establish a predetermined schedule for selling shares, providing a structured approach to liquidity that is independent of ongoing market developments or non-public information. - What is the recent performance context for the company's stock?
As of the transaction date on Aug. 31, 2026, the stock had delivered a one-year total return of 13.6%. The shares were priced at $16.07 as of the Sept. 1, 2026 market close, compared with a weighted-average execution price of $16.23 for this filing.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-09-02) | $16.81 |
| Market Capitalization | $5.4 billion |
| Revenue (TTM) | $440.3 million |
| Net Income (TTM) | -$1.4 billion |
Company Snapshot
- Core Scientific operates digital asset mining facilities and provides colocation services for distributed ledger technology infrastructure, generating revenue through proprietary cryptocurrency mining operations and hosting services for blockchain network participants.
- The company's business model leverages owned-and-operated data centers equipped with specialized computing hardware to process blockchain transactions in exchange for digital asset rewards, while simultaneously monetizing excess capacity through colocation and hosting services for enterprise clients.
- Core Scientific serves enterprise customers and digital asset mining operations seeking reliable, scalable infrastructure for blockchain network participation and cryptocurrency mining activities in North America.
Core Scientific operates as a significant North American infrastructure provider in the digital asset and blockchain technology sector, with a market capitalization of $5.4 billion and TTM revenue of $440.3 million.
The company differentiates itself through vertically integrated operations combining proprietary mining activities with third-party colocation services, enabling operational leverage and diversified revenue streams.
Despite current profitability challenges, Core Scientific maintains substantial scale, with 325 employees, and a strategic position in the growing digital asset infrastructure market.
What this transaction means for investors
This sale shouldn't concern investors. It represented a small percentage of the officer's holdings in the company's stock. The office still retains a large stake of over 1.9 million shares following the sale.
Moreover, it was executed under a pre-scheduled plan, which insiders commonly use to execute transactions for personal financial reasons, regardless of the company's fundamentals.
Although Core Scientific's financials look messy right now, with large net losses reported, analysts anticipate robust growth in the coming years. Total contracted revenue for the company's data centers has reached $24 billion for about 1.1 gigawatts of billable capacity. Analysts expect revenue to grow at an annualized rate of 90% over the next two years.
John Ballard has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.